| A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris (NCT01297166) | LEO Pharma | 2011-02-01 |
| Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults (NCT01302990) | Medicago | 2011-02-01 |
| Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer (NCT01553656) | Exelixis | 2011-02-01 |
| Personalized Medicine for Diabetes Prediction and Prevention of Complications (NCT01268813) | Rambam Health Care Campus | 2011-02-01 |
| Effects Whole Body Vibration in Ergospirometrics Parameters and Quality of Life (NCT01538888) | Universidade Federal de Pernambuco | 2011-02-01 |
| Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia (NCT01484015) | Wake Forest University Health Sciences | 2011-02-01 |
| Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted At Bedtime Or Immediately Following A 400-500 or 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers (NCT01291524) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-02-01 |
| Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118 (NCT01333904) | Pulmatrix Inc. | 2011-02-01 |
| Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance (NCT01210404) | Pfizer | 2011-02-01 |
| A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies (NCT01267084) | Janssen Research & Development, LLC | 2011-02-01 |
| Early Mobilization in Intensive Therapy (NCT01549808) | Region Zealand | 2011-02-01 |
| A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer (NCT01304602) | University of Kansas Medical Center | 2011-02-01 |
| Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia. (NCT01305694) | Guangzhou General Hospital of Guangzhou Military Command | 2011-02-01 |
| A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia (NCT01558167) | German CLL Study Group | 2011-02-01 |
| A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1 (NCT01296438) | Novo Nordisk A/S | 2011-02-01 |
| A Fmri Study on the Effects of a Conjugate Vaccine and Placebo on CNS Activation and Behavior Following a Nicotine Challenge (NCT01318668) | Maastricht University Medical Center | 2011-02-01 |
| Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes (NCT01285518) | Pfizer | 2011-02-01 |
| Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL) (NCT01292135) | Pharmacyclics LLC. | 2011-02-01 |
| Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products (NCT01321931) | McNeil AB | 2011-02-01 |
| Feasibility Study of BMAC Enhanced CABG (NCT01074099) | Harvest Technologies | 2011-02-01 |
| Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes (NCT01272804) | Pfizer | 2011-02-01 |
| Use of Topical Benzocaine for Analgesia in Lingual Frenotomy of the Newborn (NCT01274247) | Tel-Aviv Sourasky Medical Center | 2011-02-01 |
| Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions (NCT01340157) | Drugs for Neglected Diseases | 2011-02-01 |
| Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD) (NCT01301443) | Oxford BioMedica | 2011-02-01 |
| The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease (NCT01297218) | Medipost Co Ltd. | 2011-02-01 |
| Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells in Patients With Severe Critical Limb Ischemia (NCT01472289) | TotipotentSC Scientific Product Pvt. Ltd. | 2011-02-01 |
| A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function (NCT01309438) | Janssen Research & Development, LLC | 2011-02-01 |
| Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human Subjects (NCT01299285) | Eli Lilly and Company | 2011-02-01 |
| Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases (NCT01276210) | Vanderbilt-Ingram Cancer Center | 2011-02-01 |
| Safety and Pharmacokinetic Characteristics of DP-R202 in Healthy Male Volunteers (NCT01421563) | Alvogen Korea | 2011-02-01 |
| Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection (NCT02597647) | University of California, Los Angeles | 2011-02-01 |
| Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML) (NCT01422603) | University Hospital Southampton NHS Foundation Trust | 2011-02-01 |
| A Study of Danoprevir in Healthy Volunteers And Patients With Hepatic Impairment (NCT01185873) | Hoffmann-La Roche | 2011-02-01 |
| A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS (NCT01085656) | University of Florida | 2011-02-01 |
| Nuclear and Near-Infrared (NIR) Imaging in Melanoma (NCT01295931) | M.D. Anderson Cancer Center | 2011-02-01 |
| TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and Raltegravir (NCT01288755) | Tibotec Pharmaceuticals, Ireland | 2011-02-01 |
| Study of Belimumab Administered Subcutaneously to Healthy Subjects (NCT01583530) | Human Genome Sciences Inc. | 2011-02-01 |
| Rilonacept in Diabetes Mellitus Type 1: Safety Study (NCT00962026) | University of Texas Southwestern Medical Center | 2011-02-01 |
| A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese Subjects (NCT01373060) | Astellas Pharma Inc | 2011-02-01 |
| A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants (NCT01391494) | Institute of Medical Biology, Chinese Academy of Medical Sciences | 2011-02-01 |
| Rapid vs Maintenance Vitamin D Supplementation in Deficient Children With Asthma to Prevent Exacerbations. (NCT01395589) | Hamad Medical Corporation | 2011-02-01 |
| A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge (NCT01299467) | Pfizer | 2011-02-01 |
| Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid Users (NCT01380093) | Pfizer | 2011-02-01 |
| Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma (NCT01296659) | The University of Texas Health Science Center at San Antonio | 2011-02-01 |
| Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects (NCT01242826) | Novo Nordisk A/S | 2011-02-01 |
| Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia (NCT00906945) | Washington University School of Medicine | 2011-02-01 |
| Retrograde Delivery of BMAC (Bone Marrow Aspirate Concentrate) for Congestive Heart Failure (NCT01299324) | Harvest Technologies | 2011-02-01 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181. (NCT01290042) | Amgen | 2011-02-01 |
| A Study of E7080 in Subjects With Solid Tumor (NCT01268293) | Eisai Co., Ltd. | 2011-02-01 |
| GLU-xx Formulations in Individuals With Impaired Glucose Tolerance (NCT01468376) | Afexa Life Sciences Inc | 2011-02-01 |
| A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort Formulations (NCT03051893) | Neurocrine UK Limited | 2011-02-01 |
| A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects (NCT01297062) | AstraZeneca | 2011-02-01 |
| Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189 (NCT01310881) | Neuralstem Inc. | 2011-02-01 |
| Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC (NCT02175381) | Hellenic Oncology Research Group | 2011-02-01 |
| Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus (NCT01319734) | Al-Neelain University | 2011-02-01 |
| Creativity Group for Borderline Personality Disorder (NCT01343550) | State University of New York - Upstate Medical University | 2011-02-01 |
| Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes (NCT01290575) | Bristol-Myers Squibb | 2011-02-01 |
| Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose (NCT01300260) | Eli Lilly and Company | 2011-02-01 |
| Effects of Dronabinol (Oral THC) on Cannabis Use (NCT01394185) | Johns Hopkins University | 2011-02-01 |
| A Study to Test Bioequivalence Between One Test Formulation of Ibuprofen and Two Reference Treatments (NCT01316978) | McNeil AB | 2011-02-01 |
| A Drug-Drug Interaction Study Between AZD1981 and Pravastatin to Study the Effect of AZD1981 on the Kinetics of Pravastatin (NCT01254461) | AstraZeneca | 2011-02-01 |
| A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers. (NCT01301092) | Eli Lilly and Company | 2011-02-01 |
| Safety Study of X-82 in Patients With Advanced Solid Tumors (NCT01296581) | Tyrogenex | 2011-02-01 |
| Efficacy of Lanthanum Carbonate in Calciphylaxis (NCT01289626) | University of Wisconsin, Madison | 2011-02-01 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044 (NCT01419470) | Yuhan Corporation | 2011-02-01 |
| A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551) (NCT01236430) | Organon and Co | 2011-02-01 |
| A Study to Compare the Dose-proportionality of Tapentadol (CG5503) in Healthy Japanese and Korean Male Volunteers (NCT01309425) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2011-02-01 |
| Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia (NCT01408732) | University of Minnesota | 2011-02-01 |
| Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides (NCT01598454) | Laboratorio Elea Phoenix S.A. | 2011-02-01 |
| Nalrexone Facilitated Discontinuation of Buprenorphine (NCT01895036) | New York State Psychiatric Institute | 2011-02-01 |
| Drug-drug Interaction of Empagliflozin (BI 10773) and Simvastatin (NCT01304329) | Boehringer Ingelheim | 2011-02-01 |
| A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke (NCT01297413) | Stemedica Cell Technologies, Inc. | 2011-02-01 |
| Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects (NCT01306162) | Boehringer Ingelheim | 2011-02-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers (NCT01257516) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-02-01 |
| The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome (NCT01432106) | University of Michigan | 2011-02-01 |
| Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors (NCT01625611) | Yale University | 2011-02-01 |
| Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres Suspension (NCT01293747) | Productos Científicos S. A. de C. V. | 2011-02-01 |
| A Safety, Tolerability, Pharmacokinetics, and Immunogenicity Study of CNTO 6785 in Healthy Volunteers (NCT01288196) | Janssen-Cilag International NV | 2011-02-01 |
| Phase I STEBVax in Healthy Adults (NCT00974935) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-02-01 |
| Head-Mounted Vibrotactile Prosthesis for Patients With Chronic Postural Instability (NCT00889824) | Washington University School of Medicine | 2011-02-01 |
| Xolair Enhances Oral Desensitization in Peanut Allergic Patients (NCT01290913) | Lynda Schneider | 2011-02-01 |
| Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines (NCT01264445) | International AIDS Vaccine Initiative | 2011-02-01 |
| A Study to Assess the Effects of Cyclosporine on the Pharmacokinetics and Safety of Canagliflozin (JNJ-28431754) in Healthy Volunteers (NCT01718652) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2011-02-01 |
| A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Tivozanib (AV-951) in Healthy Subjects (NCT01316848) | AVEO Pharmaceuticals, Inc. | 2011-02-01 |
| Pharmacokinetic Interaction Between Ritonavir and Prasugrel in Healthy Volunteers (NCT01346800) | University Hospital, Geneva | 2011-02-01 |
| Injection Site Tolerability, Safety, Pharmacokinetics and Pharmacodynamics Study After a Single Dose Subcutaneous Treatment of Alirocumab SAR236553 (REGN727) (NCT01448239) | Sanofi | 2011-02-01 |
| LYmphadenectomy After NeoAdjuvant Chemotherapy (NCT01724944) | Catholic University of the Sacred Heart | 2011-02-01 |
| The Effect of Sonophoresis on Topical Anesthesia: A Pilot Study (NCT01283490) | Loma Linda University | 2011-02-01 |
| PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects (NCT01302925) | Peplin | 2011-02-01 |
| Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1) (NCT01294735) | Merck Sharp & Dohme LLC | 2011-02-01 |
| Effects of Transcutaneous Electrical Diaphragmatic Stimulation on Respiratory Variables in COPD Patients (NCT01300442) | Universidade Federal de Sao Carlos | 2011-02-01 |
| Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT (NCT01274377) | Nelson Chao | 2011-02-01 |
| Influence of Age on the Absorption and Metabolism of Cocoa Flavanols (NCT01790009) | University of Reading | 2011-02-01 |
| A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511 (NCT04327011) | Tocagen Inc. | 2011-02-01 |
| A Study in Non Small Cell Lung Cancer (NCT01139775) | Eli Lilly and Company | 2011-02-01 |
| Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis. (NCT00854867) | Mundipharma Research Limited | 2011-02-01 |
| To Test Bioequivalence Between Two Tablet Formulations in the Treatment of Allergy (NCT01322282) | McNeil AB | 2011-02-01 |
| Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049) (NCT01295632) | Merck Sharp & Dohme LLC | 2011-02-01 |
| 10% Carbohydrate Drink for Preventing Post-operative Nausea and Vomiting (PONV) After Spinal Morphine (NCT01301404) | Mahidol University | 2011-02-01 |
| Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors (NCT01310179) | PNP Therapeutics, Inc. | 2011-02-01 |